Quick Answer
Beam Therapeutics Inc. reported Total Revenue of $139.74 million for fiscal year 2025.
Beam Therapeutics Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $139.74M | +120.0% |
| 2024 | $63.52M | -83.2% |
| 2023 | $377.71M | +520.0% |
| 2022 | $60.92M | +17.5% |
| 2021 | $51.84M | +215916.7% |
| 2020 | $24.0K | +33.3% |
| 2019 | $18.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.70M | -32.0% | +14.6% |
| June 30, 2025 | $8.47M | -28.1% | +13.3% |
| March 31, 2025 | $7.47M | +0.8% | -47.6% |
| September 30, 2024 | $14.27M | -17.0% | +21.2% |
| June 30, 2024 | $11.77M | -41.5% | +58.9% |
| March 31, 2024 | $7.41M | -69.4% | -56.9% |
| September 30, 2023 | $17.19M | +8.8% | -14.5% |
| June 30, 2023 | $20.12M | +20.8% | -16.9% |
- Beam Therapeutics Inc. showed an increase of +120.0% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Beam Therapeutics Inc.’s total revenue has grown by 776250.0% (from $18.0 thousand to $139.74 million).
- The most recent figure is from Beam Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: